Search

everythinglearnresearchcommunity

for

Search:↓

The Italian version of a relationship scale was adapted for cancer patients, showing some differences from the original and suggesting its use could improve therapy and treatment adherence.

Alopecia areata greatly affects quality of life, especially mental health, and newer assessment tools better capture this impact than older ones.

DLQI is a reasonable quality-of-life measure for alopecia patients, but more research is needed.

Many people with alopecia experience high levels of social anxiety, anxiety, and depression, and while wigs can boost confidence, they may also cause anxiety.

People with vitiligo or alopecia areata have higher anxiety and depression than healthy people.

Anxiety about Omicron was higher in China than in North America and Western Europe.

Health workers in non-COVID wards had higher depression and anxiety rates.

Patients with Alopecia Areata often have higher anxiety and depression.

New grading scale accurately measures hair loss severity and treatment effectiveness.

Future anxiety about male pattern baldness is linked to personality traits and social perceptions.

The Turkish version of the MAIA-2 Scale is valid and reliable for patients at a dermatology clinic.

New scale reliably assesses male hair loss with female pattern.

Finasteride may increase anxiety in bright spaces.

The new measure helps understand the personal and emotional impact of hair loss in alopecia areata patients.

Alopecia areata severity is influenced by factors like long disease duration, relapses, treatment response, and mental health, leading to the creation of a new severity measurement tool.

Patients with PCOS rate their hirsutism higher than clinicians, and these self-ratings are more closely related to their quality of life and risk of depression.

Scalp photography helps patients feel less anxious about hair loss, agree more with doctors on severity, and stay motivated for treatment.

Hair loss significantly affects quality of life and mental health, causing anxiety and depression.

Mindfulness-based cognitive therapy may reduce social anxiety and improve wellbeing in people with alopecia areata.

Alopecia areata causes negative emotions and stress due to hair loss and emotional triggers.

Addressing alexithymia can improve anxiety and depression in alopecia areata patients.

Anxiety is common in hair loss patients, especially women.

Carboxytherapy did not significantly improve burn healing in rats.

Transgender women have similar fitness to cisgender women, while transgender men have higher fat and lower strength than cisgender men; hormone therapy affects body composition and strength.

Agoutis in captivity have more resting (telogen) hairs than growing (anagen) hairs, regardless of season or gender.

Creatine monohydrate is safe and effective for muscle recovery and performance, especially for those with low creatine levels.

Self-assessed hirsutism scores are not reliable for clinical diagnosis but may help in screening.

People with androgenetic alopecia often experience more anxiety, depression, and lower self-esteem.

People with alopecia areata are more likely to have anxiety and depression and a lower quality of life.

The transscrotal testosterone patch normalizes hormone levels in men with AIDS and weight loss but does not improve weight, body mass, or quality of life.